BioNTech SE Financial Liabilities
BioNTech SE (BNTX) had Financial Liabilities of EUR 1.25 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:FinancialLiabilities · last filed 2026-03-10
- 2025-12-31: Financial Liabilities 1.25B EUR.
- 2024-12-31: Financial Liabilities 2.17B EUR.
- 2022-12-31: Financial Liabilities 1.21B EUR.
- 2021-12-31: Financial Liabilities 1.66B EUR.
| Period end | Financial Liabilities | Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 1.25B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 2.17B EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 1.21B EUR 20-F · filed 2023-03-27 | |
| 2021-12-31 | 1.66B EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 448.00M EUR 20-F/A · filed 2022-10-26 | 448.03M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 105.06M EUR 20-F · filed 2021-03-30 |